Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb;18(2):61.
doi: 10.1038/s41579-019-0310-6.

New drugs for the antibacterial pipeline?

Ashley York  1
Affiliations
Comment

New drugs for the antibacterial pipeline?

Ashley York. Nat Rev Microbiol. 2020 Feb.
No abstract available

PubMed Disclaimer

Comment on

  • A new antibiotic selectively kills Gram-negative pathogens.
    Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, Honrao C, Ma X, Guo JJ, Makriyannis A, Linares-Otoya L, Böhringer N, Wuisan ZG, Kaur H, Wu R, Mateus A, Typas A, Savitski MM, Espinoza JL, O'Rourke A, Nelson KE, Hiller S, Noinaj N, Schäberle TF, D'Onofrio A, Lewis K. Imai Y, et al. Nature. 2019 Dec;576(7787):459-464. doi: 10.1038/s41586-019-1791-1. Epub 2019 Nov 20. Nature. 2019. PMID: 31747680 Free PMC article.
  • Discovery of an antivirulence compound that reverses β-lactam resistance in MRSA.
    El-Halfawy OM, Czarny TL, Flannagan RS, Day J, Bozelli JC Jr, Kuiack RC, Salim A, Eckert P, Epand RM, McGavin MJ, Organ MG, Heinrichs DE, Brown ED. El-Halfawy OM, et al. Nat Chem Biol. 2020 Feb;16(2):143-149. doi: 10.1038/s41589-019-0401-8. Epub 2019 Nov 25. Nat Chem Biol. 2020. PMID: 31768032

References

Original articles
    1. Imai, Y., Meyer, K. J. et al. A new antibiotic selectively kills Gram-negative pathogens. Nature https://doi.org/10.1038/s41586-019-1791-1 (2019) - DOI - PubMed
    1. El-Halfawy, O. M. et al. Discovery of an antivirulence compound that reverses β-lactam resistance in MRSA. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0401-8 (2019) - DOI - PubMed
Related articles
    1. Theuretzbacher, U. et al. The global preclinical antibacterial pipeline. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-019-0288-0 (2019) - DOI - PubMed
    1. Årdal, C. et al. Antibiotic development — economic, regulatory and societal challenges. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-019-0293-3 (2019) - DOI - PubMed

Substances

LinkOut - more resources